Merck Sharp & Dohme B.V. v. Warner Chilcott Company, LLC, et al., C.A. No. 13-2088 – GMS, August 26, 2016.
Sleet, J. Court issues post-trial rulings regarding validity of the patent-in-suit and Rule 52(c) motions.
The disputed technology relates to ethinyl estradiol and etonogestral vaginal ring used for contraception. The bench trial took place from January 19 through 22, 2016. The asserted claims are not invalid due to anticipation. The asserted claims are invalid as obvious.
